Related references
Note: Only part of the references are listed.Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score-Matched Cohort Study
Husam Abdel-Qadir et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
Oscar Calvillo-Arguelles et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function
Runyawan Chotenimitkhun et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Cardio-oncology Part I: chemotherapy and cardiovascular toxicity
Meabh O'Hare et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity
Meabh O'Hare et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
HMG-CoA-reductase inhibitor co-therapy lowers the risk for incident heart failure in farmorubicin recipients for two cancer locations
A. G. Tase et al.
EUROPEAN HEART JOURNAL (2014)
Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy An Observational Clinical Cohort Study
Sinziana Seicean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Zeydin Acar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Share Paper
